ArticleGlobalization and health2026
Corporate influence on food and nutrition policies in Latin America and the Caribbean: key determinants and policy directions.
Article in Globalization and health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIn Latin America and the Caribbean (LAC), diets are increasingly dominated by ultra-processed products (UPPs). Although public health policies aimed at reducing UPPs consumption show promise, these are often undermined by corporate influence. Understanding how countries respond to this influence is essential for strengthening food policy development in LAC.
objectiveExamine how different sectors (government, academia, and civil society organizations) respond to corporate influence throughout the public policy cycle and analyze the key determinants that enable or constrain industry power across six analytical environments in five LAC countries, with the aim of informing actionable policy directions.
methodsThe study follows two sequential and complementary components: (1) policy mapping conducted to assess the progress of six health, food, and nutrition policies within the policy cycle in LAC countries, and (2) a qualitative component consisting of in-depth interviews with key informants from Guatemala, Paraguay, Argentina, Jamaica and Barbados; conducted between May 2024 and May 2025. Data analysis followed a constant comparative approach to identify cross-cutting patterns and context-specific insights.
resultsPolicy progress varies substantially across food policies and countries. For example, taxation on sugar-sweetened beverages is generally advanced, while marketing restrictions on unhealthy products remain at earlier stages. Regarding the qualitative component, fifteen informants were interviewed; Argentina and academia were the most represented. Based on informants´ responses, corporate strategies and counterstrategies were identified and classified into six environments, each comprising determinants that either constrain corporate power or hinder efforts to address it. These encompassed: (1) political and governance processes; (2) legal and regulatory frameworks, as evidenced in Argentina and Jamaica; (3) narrative and communication strategies leveraging media; (4) knowledge production and dissemination characterized by misleading or suppressed information; (5) advocacy efforts, notably observed in Argentina and the Caribbean; and (6) a cross-cutting, cross-sectoral collaboration to present a unified response to corporate influence.
conclusionFindings indicate that the UPPs industry operates across multiple environments and is shaped by country-specific contexts. Nevertheless, promising responses include transparency and conflict-of-interest mechanisms, strengthened civil society advocacy, and cross-sectoral collaboration to counter corporate influence. These strategies require adaptation to national and local conditions. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.